Tag: brainomix
Brainomix extends Series C financing beyond US$25 million in support of...
Brainomix has announced a US$6.5 million (£4.8 million) extension to its Series C financing, adding to the funding it secured in March 2025 and...
Brainomix to launch next-generation stroke platform equipped with net water uptake...
Brainomix has announced the upcoming launch of its new Brainomix 360 next-generation platform at the International Stroke Conference (ISC; 4–6 February 2026, New Orleans,...
Brainomix AI technology reveals efficacy of novel neuroprotective drug in severe...
Brainomix has announced results from its partnership with Argenica Therapeutics involving imaging and clinical data analysis of a phase two trial evaluating ARG-007—a neuroprotective...
Real-world study shows marked EVT uptick and reduced delays with Brainomix...
Brainomix has announced the publication of a prospective real-world study demonstrating that its artificial intelligence (AI) imaging platform, Brainomix 360 Stroke, significantly increased rates...
Brainomix’s AI-powered stroke technology gains mainstream media attention in UK
Brainomix has garnered widespread media attention this week—from mainstream UK news outlets including The Times, The Guardian, The Telegraph and The Mirror—following a renewed focus...
Brainomix and 3DR Labs partner to advance US stroke care
Brainomix and 3DR Labs have announced a new strategic partnership to support acute stroke care in the USA through the clinically validated and US...
Brainomix announces multiple study presentations highlighting clinical impact of 360 Stroke...
Brainomix has announced the recent presentation of a series of studies at the European Stroke Organisation Conference (ESOC; 21–23 May, Helsinki, Finland), providing new...
Brainomix gains US FDA clearance for new core volume assessment feature
Brainomix has announced the US Food and Drug Administration (FDA) clearance of a novel and patented feature that enables physicians to assess ischaemic core...
Brainomix completes £14 million Series C funding round
Brainomix recently announced the completion of a £14 million (US$18 million) Series C investment round co-led by prominent health technology investors, including existing investors...
Brainomix and Medtronic partner to enhance stroke care in Western Europe...
This press release has been sponsored by Medtronic.
Brainomix, a pioneer in stroke artificial intelligence (AI) imaging software has announced a strategic partnership with Medtronic...
New data presented at ISC 2025 further validate treatment impact of...
Brainomix will be unveiling a series of new studies this week at the International Stroke Conference (ISC; 5–7 February, Los Angeles, USA), further validating...
Brainomix announces presentation of US data validating AI technology in stroke...
Brainomix has announced new data from studies that were presented this week at the Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado...
Brainomix announces increased thrombectomy rates at UK centres using its AI...
Brainomix has announced that results from what it claims is the largest prospective study of stroke artificial intelligence (AI) software were presented yesterday at...
New UK NICE guidance endorses AI-derived software in stroke assessments
A new guidance document from the UK National Institute of Health and Care Excellence (NICE) has endorsed National Health Service (NHS) deployment of two...
Brainomix targets US expansion following launch of 360 platform at SVIN...
Brainomix has heralded its continued US expansion with the launch of a full suite of US Food and Drug Administration (FDA)-cleared modules in its...
Brainomix and Nanoflex to work on AI-assisted robotic system for remote...
Brainomix and Nanoflex Robotics have announced today that they have been awarded a grant via the ‘UK—Switzerland Bilateral: Collaborative R&D ’ programme, under which...
Report finds improved thrombectomy access at NHS hospitals using Brainomix’s AI...
More stroke patients are benefitting from life-changing treatment thanks to Brainomix's e-Stroke artificial intelligence (AI) platform, according to a recent report from the Oxford...
Brainomix receives US FDA clearance for flagship stroke AI imaging software
Brainomix has today announced that its 360 e-ASPECTS tool for stroke has received US Food and Drug Administration (FDA) clearance, enabling the company to...
Brainomix technology integrated into new UK atrial fibrillation study
Brainomix has announced its involvement in a new study sponsored by the University of Liverpool (Liverpool, UK) focused on post-stroke atrial fibrillation (AF). Sites...
Blackford and Brainomix announce partnership to advance AI-assisted stroke care
Blackford—an artificial intelligence (AI) imaging platform and solutions provider—is set to form a strategic partnership with Brainomix to bring the latter’s comprehensive e-Stroke solution...
Brainomix and Visionable announce partnership to optimise UK stroke care pathway
Brainomix is set to strategically partner with Visionable, a real-time clinical collaboration platform designed to enable virtual healthcare models, in an attempt to transform...
Brainomix awarded tender to roll out AI imaging software across all...
Brainomix has announced that it has been awarded the national tender in Hungary to deploy its artificial intelligence (AI) stroke imaging software across all stroke centres...
Brainomix launches e-Stroke 11 to enhance stroke network communications and workflow
Brainomix has announced the launch of e-Stroke 11, the latest version of the company's AI-powered stroke imaging platform. According to a Brainomix press release,...
New study finds e-Stroke software shortens treatment times and improves functional...
A new study presented at the 13th World Stroke Congress (WSC 2021; 28–29 October, virtual) found that the implementation of Brainomix's e-Stroke software resulted in...
Brainomix launches AI stroke software across Poland under POLKARD initiative
Brainomix has deployed its flagship artificial intelligence (AI)-based e-Stroke software across the majority of the largest comprehensive stroke centres in Poland, allowing the company...
Stryker partners with Brainomix for AI stroke software
Stryker has announced a new partnership with Brainomix that provides an option for European customers to purchase Brainomix’s e-Stroke software.
According to a press release...
Brainomix achieves ‘breakthrough’ in stroke imaging with new software release
Brainomix has announced the launch of the latest version of the company's stroke imaging platform, e-Stroke Suite 10.0, which includes clot detection from non-contrast computed tomography (CT) scans and is designed to...
Although “unperfected”, AI has the potential to accelerate and synchronise stroke...
A recently published systematic review reveals that artificial intelligence (AI) is rapidly being used by major medical centres to identify large vessel occlusions (LVO)...
